---
figid: PMC6562634__cells-08-00468-g003
figtitle: Schematic model of regulation of the Hippo pathway by numerous signaling
  pathways in cancer
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Drosophila melanogaster
- Lareunionomyces loeiensis
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Drosophila melanogaster
- Danio rerio
pmcid: PMC6562634
filename: cells-08-00468-g003.jpg
figlink: /pmc/articles/PMC6562634/figure/cells-08-00468-f003/
number: F3
caption: Schematic model of regulation of the Hippo pathway by numerous signaling
  pathways in cancer. (a) Integrin-ILK signaling inhibits MYPT1, leading to inactivation
  of the MST1/2-LATS1/2 kinase cascade, which triggers YAP/TAZ activation. (b) RAC1
  and PAK1 phosphorylate NF2 that inhibits the interaction between YAP and NF2, resulting
  in YAP/TAZ activation. (c) Integrin-FAK signaling activates the RhoA-ROCK pathway
  to control remodeling of the actin cytoskeleton. (d) In response to ECM, Agrin enhances
  RhoA-ROCK-dependent actin cytoskeletal remodeling. As a later event, YAP/TAZ are
  translocated to the nucleus to interact with transcription factors (TFs), which
  drive profibrotic and tumorigenic effects.
papertitle: Role of the Hippo Pathway in Fibrosis and Cancer.
reftext: Cho-Long Kim, et al. Cells. 2019 May;8(5):468.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.923082
figid_alias: PMC6562634__F3
figtype: Figure
redirect_from: /figures/PMC6562634__F3
ndex: f9196090-df0d-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6562634__cells-08-00468-g003.html
  '@type': Dataset
  description: Schematic model of regulation of the Hippo pathway by numerous signaling
    pathways in cancer. (a) Integrin-ILK signaling inhibits MYPT1, leading to inactivation
    of the MST1/2-LATS1/2 kinase cascade, which triggers YAP/TAZ activation. (b) RAC1
    and PAK1 phosphorylate NF2 that inhibits the interaction between YAP and NF2,
    resulting in YAP/TAZ activation. (c) Integrin-FAK signaling activates the RhoA-ROCK
    pathway to control remodeling of the actin cytoskeleton. (d) In response to ECM,
    Agrin enhances RhoA-ROCK-dependent actin cytoskeletal remodeling. As a later event,
    YAP/TAZ are translocated to the nucleus to interact with transcription factors
    (TFs), which drive profibrotic and tumorigenic effects.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Agrn
  - Ilk
  - Ptk2
  - Akt1
  - Nf2
  - Pak1
  - Pkn1
  - Large1
  - Mst1
  - Stk4
  - Stk3
  - Lats1
  - Lats2
  - Lrp4
  - Corin
  - Musk
  - Lat
  - AGRN
  - ILK
  - PTK2
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - NF2
  - PAK1
  - PKN1
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - LARGE1
  - MST1
  - STK4
  - STK3
  - LATS1
  - LATS2
  - LRP4
  - CORIN
  - MUSK
  - scb
  - Fak
  - Rac1
  - Rac2
  - Akt
  - Mtl
  - Mer
  - Pak
  - Act5C
  - Act42A
  - Act57B
  - Act79B
  - Act88F
  - Act87E
  - Mst57Dc
  - Mst57Db
  - Mst57Da
  - mst
  - hpo
  - wts
  - Mbs
  - ilk
  - ptk2ab
  - nf2b
  - pak1
  - large1
  - mst1
  - lats1
  - lats2
  - lrp4
  - musk
---
